MS Market Outlook Good for Prescription Drugs List Medication, Alemtuzumab
Prescription Drugs List News - Genzyme Corporation, a leading biotechnology firm focused on rare inherited disorders has revealed intense market research on Alemtuzumab; a prescription drug developed for use in the treatment of Multiple Sclerosis (MS). Alemtuzumab has several features making the prescription drug attractive to providers and patients.
Tue, 12/21/2010 - 06:17 
The prescription drug list for sufferers of menopause is about to get longer. On August 30, 2010 the FDA gave approval for Phase III clinical testing of Menerba by Bionovo, a prescription drug to treat hot flashes.